L Rizzo, A D'Andrea, N Stella, P Orlando, M Taurino
{"title":"糖尿病对股浅动脉再通效果的影响是有争议的。","authors":"L Rizzo, A D'Andrea, N Stella, P Orlando, M Taurino","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Notwithstanding technological improvements in endovascular devices treatment of steno-obstructive lesions of the superficial femoral artery (SFA) remains a challenge for today's vascular surgeon. Current opinion dictates that the diabetic population may have worse outcome after revascularization of the lower extremities. Herein we examine the effects of endovascular treatment on steno-obstructive lesions of the SFA in diabetic and non-diabetic patients.</p><p><strong>Methods: </strong>A retrospective analysis was carried out on 110 patients who had undergone endovascular treatment of the SFA from 2010 to 2017 comparing outcomes in diabetic (DM) <i>vs</i> non-diabetic patients (nDM).</p><p><strong>Results: </strong>56 (50.9%) of the patients were diabetic and 54 were non-diabetic (49.1%). 52.7% (62.7% DM vs 35.2% nDM, p = 0.0003) were patients with critical limb ischemia. SFA occlusion was present in 65.5% (60.7% DM vs 70.4% nDM, p = 0.29) of all patients. All had undergone PTA of the SFA and 40.9% had received adjunctive stenting (44.6% DM vs 37.0% nDM, p = 0.41). A multilevel treatment was executed in 39.1% (51.8% DM vs 25.9% nDM) of the cases whereas an infra-popliteal procedure was associated in 27.3% (37.5% DM vs 16.7% nDM). In both groups the presence of diabetes was significantly associated (p = 0.005 e p = 0.014, respectively). Reintervention rate was 22.7%; 13 in the diabetic group (23.2%) and 12 in the non-diabetic group (22.2%). Of those who had had reintervention (p = 0.77); 9 patients (8.2%) had undergone an open surgical operation, 6 of whom had diabetes (p = 0.32). 5 patients (4.5%) had had major amputation, 4 of whom were diabetic (p = 0.20). Curves assessing freedom from target lesion restenosis were substantially overlapping between the two groups.</p><p><strong>Conclusion: </strong>No statistical associations between diabetes and reintervention or amputation rates were found. Indication to treat the SFA were not influenced by the presence of diabetes but further investigation is required to verify our hypothesis.</p>","PeriodicalId":54170,"journal":{"name":"Translational Medicine at UniSa","volume":"21 ","pages":"10-18"},"PeriodicalIF":1.1000,"publicationDate":"2020-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039259/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Influence of Diabetes Mellitus on the Outcome of Superficial Femoral Artery Recanalization is Debatable.\",\"authors\":\"L Rizzo, A D'Andrea, N Stella, P Orlando, M Taurino\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Notwithstanding technological improvements in endovascular devices treatment of steno-obstructive lesions of the superficial femoral artery (SFA) remains a challenge for today's vascular surgeon. Current opinion dictates that the diabetic population may have worse outcome after revascularization of the lower extremities. Herein we examine the effects of endovascular treatment on steno-obstructive lesions of the SFA in diabetic and non-diabetic patients.</p><p><strong>Methods: </strong>A retrospective analysis was carried out on 110 patients who had undergone endovascular treatment of the SFA from 2010 to 2017 comparing outcomes in diabetic (DM) <i>vs</i> non-diabetic patients (nDM).</p><p><strong>Results: </strong>56 (50.9%) of the patients were diabetic and 54 were non-diabetic (49.1%). 52.7% (62.7% DM vs 35.2% nDM, p = 0.0003) were patients with critical limb ischemia. SFA occlusion was present in 65.5% (60.7% DM vs 70.4% nDM, p = 0.29) of all patients. All had undergone PTA of the SFA and 40.9% had received adjunctive stenting (44.6% DM vs 37.0% nDM, p = 0.41). A multilevel treatment was executed in 39.1% (51.8% DM vs 25.9% nDM) of the cases whereas an infra-popliteal procedure was associated in 27.3% (37.5% DM vs 16.7% nDM). In both groups the presence of diabetes was significantly associated (p = 0.005 e p = 0.014, respectively). Reintervention rate was 22.7%; 13 in the diabetic group (23.2%) and 12 in the non-diabetic group (22.2%). Of those who had had reintervention (p = 0.77); 9 patients (8.2%) had undergone an open surgical operation, 6 of whom had diabetes (p = 0.32). 5 patients (4.5%) had had major amputation, 4 of whom were diabetic (p = 0.20). Curves assessing freedom from target lesion restenosis were substantially overlapping between the two groups.</p><p><strong>Conclusion: </strong>No statistical associations between diabetes and reintervention or amputation rates were found. Indication to treat the SFA were not influenced by the presence of diabetes but further investigation is required to verify our hypothesis.</p>\",\"PeriodicalId\":54170,\"journal\":{\"name\":\"Translational Medicine at UniSa\",\"volume\":\"21 \",\"pages\":\"10-18\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2020-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039259/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Medicine at UniSa\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Medicine at UniSa","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
尽管血管内装置的技术进步,治疗股浅动脉狭窄梗阻病变(SFA)仍然是当今血管外科医生的一个挑战。目前的观点认为,糖尿病患者在下肢血运重建术后可能会有更糟糕的结果。本文研究了血管内治疗对糖尿病和非糖尿病患者SFA狭窄梗阻性病变的影响。方法:回顾性分析2010年至2017年接受血管内治疗的110例SFA患者,比较糖尿病(DM)与非糖尿病(nDM)患者的结局。结果:糖尿病56例(50.9%),非糖尿病54例(49.1%)。52.7% (62.7% DM vs 35.2% nDM, p = 0.0003)为重度肢体缺血患者。65.5% (60.7% DM vs 70.4% nDM, p = 0.29)的患者存在SFA闭塞。所有患者均接受了SFA PTA, 40.9%的患者接受了辅助支架植入术(44.6% DM vs 37.0% nDM, p = 0.41)。39.1% (51.8% DM vs 25.9% nDM)的病例进行了多水平治疗,而27.3% (37.5% DM vs 16.7% nDM)的病例进行了腘下手术。在两组中,糖尿病的存在显著相关(分别p = 0.005和p = 0.014)。再干预率为22.7%;糖尿病组13例(23.2%),非糖尿病组12例(22.2%)。再干预组(p = 0.77);9例(8.2%)患者曾行开放性手术,其中6例合并糖尿病(p = 0.32)。5例(4.5%)截肢,其中糖尿病患者4例(p = 0.20)。两组评估目标病灶再狭窄自由度的曲线基本重叠。结论:糖尿病与再干预或截肢率之间无统计学关联。治疗SFA的适应症不受糖尿病的影响,但需要进一步的研究来验证我们的假设。
The Influence of Diabetes Mellitus on the Outcome of Superficial Femoral Artery Recanalization is Debatable.
Notwithstanding technological improvements in endovascular devices treatment of steno-obstructive lesions of the superficial femoral artery (SFA) remains a challenge for today's vascular surgeon. Current opinion dictates that the diabetic population may have worse outcome after revascularization of the lower extremities. Herein we examine the effects of endovascular treatment on steno-obstructive lesions of the SFA in diabetic and non-diabetic patients.
Methods: A retrospective analysis was carried out on 110 patients who had undergone endovascular treatment of the SFA from 2010 to 2017 comparing outcomes in diabetic (DM) vs non-diabetic patients (nDM).
Results: 56 (50.9%) of the patients were diabetic and 54 were non-diabetic (49.1%). 52.7% (62.7% DM vs 35.2% nDM, p = 0.0003) were patients with critical limb ischemia. SFA occlusion was present in 65.5% (60.7% DM vs 70.4% nDM, p = 0.29) of all patients. All had undergone PTA of the SFA and 40.9% had received adjunctive stenting (44.6% DM vs 37.0% nDM, p = 0.41). A multilevel treatment was executed in 39.1% (51.8% DM vs 25.9% nDM) of the cases whereas an infra-popliteal procedure was associated in 27.3% (37.5% DM vs 16.7% nDM). In both groups the presence of diabetes was significantly associated (p = 0.005 e p = 0.014, respectively). Reintervention rate was 22.7%; 13 in the diabetic group (23.2%) and 12 in the non-diabetic group (22.2%). Of those who had had reintervention (p = 0.77); 9 patients (8.2%) had undergone an open surgical operation, 6 of whom had diabetes (p = 0.32). 5 patients (4.5%) had had major amputation, 4 of whom were diabetic (p = 0.20). Curves assessing freedom from target lesion restenosis were substantially overlapping between the two groups.
Conclusion: No statistical associations between diabetes and reintervention or amputation rates were found. Indication to treat the SFA were not influenced by the presence of diabetes but further investigation is required to verify our hypothesis.